Related content

Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide

By Blumsohn A.   Marin F.   Nickelsen T.   Brixen K.   Sigurdsson G.   González de la Vera J.   Boonen S.   Liu-Léage S.   Barker C.   Eastell R.  

Osteoporosis International, Vol. 22, Iss. 6, 2011-06 ,pp. : 1935-1946

Springer Publishing Company

Access to resources Recommend Favorite

Changes in bone mineral density, bone turnover markers, and vertebral fracture risk reduction with once weekly teriparatide

By Tanaka Shiro   Kuroda Tatsuhiko   Sugimoto Toshitsugu   Nakamura Toshitaka   Shiraki Masataka  

Current Medical Research and Opinion, Vol. 30, Iss. 5, 2014-05 ,pp. : 931-936

Informa Healthcare

Access to resources Recommend Favorite

Bone density after teriparatide in patients with or without prior antiresorptive treatment: one-year results from the EUROFORS study*

By Minne Helmut   Audran Maurice   Simõões Maria E.   Obermayer-Pietsch Barbara   Sigurððsson Gunnar   Maríín Fernando   Dalsky Gail P.   Nickelsen Thomas    

Current Medical Research and Opinion, Vol. 24, Iss. 11, 2008-11 ,pp. : 3117-3128

Informa Healthcare

Access to resources Recommend Favorite

The importance of bisphosphonate therapy in maintaining bone mass in men after therapy with teriparatide [human parathyroid hormone(1–34)]

By Kurland Etah   Heller Samantha   Diamond Beverly   McMahon Donald   Cosman Felicia   Bilezikian John  

Osteoporosis International, Vol. 15, Iss. 12, 2004-12 ,pp. : 992-997

Springer Publishing Company

Access to resources Recommend Favorite

The effectiveness of teriparatide in the clinical practice-attenuation of the bone mineral density outcome by increasing age and bisphosphonate pretreatment

By Koski Anna-Mari  

Annals of Medicine, Vol. 45, Iss. 3, 2013-05 ,pp. : 230-235

Informa Healthcare

Access to resources Recommend Favorite